FDA recently approved Trevena Inc.’s Olinvyk (oliceridine), an opioid used to manage severe acute pain in adults who require an intravenous opioid and who have been unresponsive to alternative...
Eli Lilly and Company recently announced the initiation of a Phase 3 trial, BLAZE-2, studying potential COVID-19 antibody treatment in residents and staff at nursing facilities across the US.
For more...
Members of the COVID R&D Alliance, Abbvie, Amgen, and Takeda Pharmaceutical, recently announced that the first patients were enrolled in the I-SPY COVID clinical trial, which will evaluate the...
Sanofi and Regeneron Pharmaceuticals recently announced that the US Phase 3 COVID-19 clinical trial of Kevzara in patients requiring mechanical ventilation did not meet its primary and key secondary...
FDA is teaming up with the Critical Path Institute and National Center for Advancing Translational Sciences (NCATS) to launch the CURE Drug Repurposing Collaboratory (CDRC) to evaluate existing drugs...
The World Health Organization (WHO) temporarily paused the use of hydroxychloroquine (HCQ) in its Solidarity trial based on study results which showed the drug was not effective in treating...
Roche recently announced positive phase 3 results from a study evaluating Venclexta (venetoclax) in individuals with untreated acute myeloid leukemia (AML) who were ineligible for intensive induction...
New real-world data recently showed that Trulicity had significantly higher patient adherence and longer persistence compared to weekly injections of semaglutide or exenatide in individuals with type 2...
Preliminary data from a clinical trial found that a commonly used steroid – dexamethasone – improves survival in hospitalized COVID-19 patients, according to a press release from Oxford...
Merck recently announced that the FDA approved a supplemental New Drug Application for Recarbrio, a drug targeting the source of some hospital-acquired infections.
Recarbrio is a combination of...
AstraZeneca recently partnered with Accent Therapeutics to discover, develop, and commercialize novel cancer therapeutics targeting RNA-modifying proteins (RMPs).
The companies will focus on targeting...
Pharmaceutical companies are continuing to boost their efforts to combat COVID-19. Although cases have greatly declined since the start of the pandemic in mid-March, there are still nearly two million...
A recent analysis of a randomized clinical trial found that the administration of D-cycloserine (DCS) enhanced exposure therapy for social anxiety disorder (SAD) when given before or after the exposure...
Sanofi recently announced that when Sarclisa (isatuximab), a monoclonal antibody, is added to carfilozomib and dexamethasone, it reduces the risk of relapsed multiple myeloma progression or death in...
An antibody isolated from a patient who recovered from severe acute respiratory syndrome (SARS) in 2003 could be a potential therapeutic COVID-19 antibody, according to a study recently published in...
An FDA-approved antiviral drug used to treat herpes simplex virus I infection (HSV-1) may be effective for treating plaque formation and other markers of Alzheimer’s disease, according to a new...
Using two different alternative pricing models, the Institute for Clinical and Economic Review (ICER) determined that the price for remdesivir could range from $10 to over $4,000.
For more coronavirus...
Eli Lilly Company and Junshi Biosciences recently entered into an agreement to co-develop COVID-19 antibody therapies for the prevention and treatment of the novel coronavirus.
For more coronavirus...
GSK recently announced that the FDA approved its PARP inhibitor monotherapy maintenance treatment for women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in...
Alveo Technologies recently announced a collaboration with Janssen Pharmaceuticals, part of Johnson & Johnson, to advance the company’s at-home testing platform that detects viral infections,...
